Learning about personal genetic risk for cannabis-psychosis made people more likely to avoid marijuana
In two experiments totaling 1,601 young adults, receiving hypothetical genetic test results showing heightened schizophrenia risk from marijuana increased intentions to avoid cannabis, especially among prior users.
Quick Facts
What This Study Found
Participants told they had a genetic predisposition for marijuana to increase schizophrenia risk rated the likelihood and importance of avoiding marijuana as significantly higher than controls. In the nationally representative sample, this effect was strongest among those who had previously used marijuana. Conversely, being told one lacked such a predisposition tended to lower avoidance intentions, raising concerns about a "genetic license" effect.
Key Numbers
Experiment 1: 801 participants (Mechanical Turk). Experiment 2: 800 participants (nationally representative, ages 18-30). Predisposition condition: increased avoidance intentions. No-predisposition condition: decreased avoidance in Experiment 1. Prior marijuana use moderated effects in Experiment 2.
How They Did This
Two randomized experiments. Experiment 1: 801 US young adults from Mechanical Turk. Experiment 2: 800 nationally representative US adults aged 18-30. Participants randomized to three conditions: genetic predisposition present, absent, or no genetic testing (control). Measured intentions to avoid marijuana.
Why This Research Matters
As genetic testing becomes more common, understanding how personalized risk information affects substance use behavior is critical. This study suggests genetic cannabis-psychosis risk information could be a powerful prevention tool, but the "no predisposition" condition raises ethical concerns.
The Bigger Picture
The finding that prior marijuana users were most responsive to genetic risk information is encouraging for targeted prevention. However, the risk that genetic "all-clear" results could reduce caution (the genetic license effect) needs careful consideration before implementing such testing.
What This Study Doesn't Tell Us
Hypothetical scenarios, not actual genetic tests. Self-reported intentions may not predict behavior. Mechanical Turk sample in Experiment 1 may not be representative. Short-term measurement only.
Questions This Raises
- ?Would real genetic test results produce similar behavioral changes?
- ?How should genetic cannabis risk information be communicated to minimize the "license" effect?
- ?Would personalized genetic counseling be effective for cannabis prevention?
Trust & Context
- Key Stat:
- Genetic predisposition information increased marijuana avoidance, especially in prior users
- Evidence Grade:
- Two randomized experiments with adequate samples, one nationally representative. Limited by hypothetical scenarios and self-reported intentions.
- Study Age:
- 2021 experimental study.
- Original Title:
- Experimentally exploring the potential behavioral effects of personalized genetic information about marijuana and schizophrenia risk.
- Published In:
- Journal of psychiatric research, 140, 316-322 (2021)
- Database ID:
- RTHC-03279
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
Could genetic testing prevent marijuana use?
This study suggests that learning about a personal genetic predisposition for cannabis-related schizophrenia risk increased intentions to avoid marijuana, especially among those who had already tried it. However, intentions may not translate to behavior.
Is there a downside to genetic testing for cannabis risk?
Potentially. Participants told they lacked a genetic predisposition showed decreased avoidance intentions in one experiment, suggesting a "genetic license" effect where the absence of genetic risk could encourage risky behavior.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-03279APA
Lebowitz, Matthew S; Appelbaum, Paul S; Dixon, Lisa B; Girgis, Ragy R; Wall, Melanie M. (2021). Experimentally exploring the potential behavioral effects of personalized genetic information about marijuana and schizophrenia risk.. Journal of psychiatric research, 140, 316-322. https://doi.org/10.1016/j.jpsychires.2021.05.066
MLA
Lebowitz, Matthew S, et al. "Experimentally exploring the potential behavioral effects of personalized genetic information about marijuana and schizophrenia risk.." Journal of psychiatric research, 2021. https://doi.org/10.1016/j.jpsychires.2021.05.066
RethinkTHC
RethinkTHC Research Database. "Experimentally exploring the potential behavioral effects of..." RTHC-03279. Retrieved from https://rethinkthc.com/research/lebowitz-2021-experimentally-exploring-the-potential
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.